These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 13251255)
81. Thorazine-Rauwolfia serpentina combination in the treatment of essential hypertension; preliminary report. EIBER HB Bull N Y Acad Med; 1955 May; 31(5):407-8. PubMed ID: 14364088 [No Abstract] [Full Text] [Related]
82. [Research on the effects of an active principle of Rauwolfia serpentina (serpasil) on the cephaloretinal circulation in hypertensive patients]. LEONARDI F Boll Ocul; 1955 Dec; 34(12):741-50. PubMed ID: 13304185 [No Abstract] [Full Text] [Related]
83. [Action of chlorpromazine and reserpine on symptomatologic manifestations of psychoneuroses]. GOMITATO G Arch Psicol Neurol Psichiatr; 1956; 17(2-3):531-43. PubMed ID: 13341422 [No Abstract] [Full Text] [Related]
84. [Renal hemodynamics and function during the treatment of hypertension with an extract from Rauwolfia serpentina - rivadescine]. BROD J; FENCL V Vnitr Lek; 1955 Jul; 1(7):539-44. PubMed ID: 13257028 [No Abstract] [Full Text] [Related]
85. A long-term study of the effect of crude Rauwolfia serpentina and of its alseroxylon fraction in patients with hypertension. GREEN RS; DAVOLOS D Am J Med; 1956 May; 20(5):760-73. PubMed ID: 13313574 [No Abstract] [Full Text] [Related]
86. [Neuropsychiatric experience with the effects of rauwolfia alkaloids reserpin (serpasil)]. FLUGEL F Med Klin; 1955 Mar; 50(13):509-10. PubMed ID: 14383137 [No Abstract] [Full Text] [Related]
87. [New observations on the treatment of arterial hypertension with total alkaloids of Rauwolfia serpentina or sarpagandah]. Pieri J; Wahl M Concours Med; 1956 Dec; 78(48):5061-8. PubMed ID: 13383996 [No Abstract] [Full Text] [Related]
88. Management of hypertension with sustained-release reserpine. GAGNIER GE Int Rec Med Gen Pract Clin; 1956 Aug; 169(8):522-5. PubMed ID: 13345515 [No Abstract] [Full Text] [Related]
89. [Reserpine: therapeutic use in schizophrenia; preliminary note]. MURATTI JB Dia Med; 1956 May; 28(33):880-3. PubMed ID: 13344248 [No Abstract] [Full Text] [Related]
92. Federal ruling on products containing reserpine and Rauwolfia products issued by the Food and Drug Administration of the U.S. Department of Health, Education, and Welfare. SMITH RG R I Med J; 1956 Sep; 39(9):512-4. PubMed ID: 13371204 [No Abstract] [Full Text] [Related]
94. Clinical experience with a sustained-release preparation of reserpine. BECK TA Int Rec Med Gen Pract Clin; 1955 Dec; 168(12):807-11. PubMed ID: 13278074 [No Abstract] [Full Text] [Related]
98. Combined chlorpromazine-Rauwolfia serpentina therapy in essential hypertension; preliminary report. EIBER HB J Am Med Assoc; 1955 Jul; 158(9):730-1. PubMed ID: 14381248 [No Abstract] [Full Text] [Related]
99. [Apropos of the antiacetylcholine effects of different Rauwolfia alkaloids and several intermediary substances obtained during the synthesis of reserpine]. CASTIAU J C R Seances Soc Biol Fil; 1960; 154():445-7. PubMed ID: 13808307 [No Abstract] [Full Text] [Related]
100. Reserpine for the cardiac patient. HALPRIN H J Med Soc N J; 1955 Dec; 52(12):616-8. PubMed ID: 13271962 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]